Resources
13 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 3/10/2021 (updated 4/5/2024)
The 2020 National Drug Threat Assessment (NDTA) is a comprehensive assessment of the threat posed to the United States by the trafficking and abuse of illicit drugs, the diversion and abuse of licit drugs, and the laundering of proceeds generated through illicit drug sales. It also addresses the role domestic groups, including organized violent gangs, serve in domestic drug trafficking. The most widely trafficked drugs are discussed in terms of their availability, consumption and overdose related deaths, production and cultivation, transportation, and distribution.
Posted 3/2/2021 (updated 4/5/2024)
Posted 10/14/2021 (updated 4/3/2024)
Rural Community Opioid Response Program (RCORP) grantees discussed their efforts and initiatives working with criminal justice and corrections agencies to engage individuals who are incarcerated.
Posted 8/11/2020 (updated 4/2/2024)
Non-fatal opioid overdose (NFOO) is a significant cause of opioid-related morbidity in the United States. As the number of NFOOs continues to grow, it is important to understand the short- and long-term consequences of NFOO. This report examines the existing literature on the acute and chronic health and functional outcomes of individuals who experience NFOO, and also identifies differences in outcomes for NFOOs involving illicitly-manufactured fentanyl.
Posted 11/21/2019 (updated 3/28/2024)
Law Enforcement Assisted Diversion (LEAD) uses police diversion and community-based, trauma-informed care systems, with the goals of improving public safety and public order, and reducing law violations by people who participate in the program.
Posted 7/16/2020 (updated 3/28/2024)
The National Health Service Corps (NHSC) New Site Application webinar took place on Thursday, July 2, 2020, at 2:00 PM ET.
Posted 10/27/2023 (updated 3/28/2024)
As announced by the Substance Abuse and Mental Health Services Administration in January 2023, clinicians no longer need a federal waiver to prescribe buprenorphine for treatment of opioid use disorder. Clinicians will still be required to register with the federal Drug Enforcement Agency (DEA) to prescribe controlled medications. On June 27, the DEA began to require that registration applicants – both new and renewing – affirm they have completed a new, one-time, eight-hour training.
Posted 3/7/2023 (updated 3/27/2024)
Qualify for tax-free educational loan repayment while becoming part of the solution to increase access to health care in your community. Join more than 18,000 National Health Service Corps (NHSC) members providing culturally competent care to medically underserved people across the country.
Posted 1/31/2023 (updated 3/27/2024)
Training Material
Posted 6/7/2022 (updated 3/27/2024)
The presentation outlined how the Law Enforcement Assisted Diversion/Let Everyone Advance with Dignity (LEADD) pre-arrest diversion initiative operates. It covered how public health partners can engage with law enforcement to bring about a true collaborative approach to public safety. It further discussed how the LEAD model is rooted in harm reduction.